Advent International to acquire a significant stake in Suven Pharmaceuticals
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Miravo to remain a Canadian controlled and operated company following closing of the transaction
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
LG Chem will receive totaling up to $95.5 million for the China rights
The investment will enable the company to enter European markets as well as enhance margins in current markets
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
EC grants conditional marketing authorization based on the EFFISAYIL trial
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
Subscribe To Our Newsletter & Stay Updated